Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
1996-3-7
|
| pubmed:abstractText |
In order to test whether the beta-adrenoceptor activity in rheumatic heart valvular disease depends on the ventricular load conditions, we determined their density and binding affinity to [125I]-iodocyanopindolol in lymphocytes, as well as plasma catecholamine and cAMP levels in 69 patients with regurgitant and stenotic lesions of the aortic and mitral valves. The patients were classified as having left ventricular pressure overload (LVP), left ventricular volume overload (LVV), mixed lesions (MOL) or right ventricular pressure overload (RVP). The beta-adrenoceptor activity was determined by radioligand binding methods, catecholamines by high performance liquid chromatography using an electrochemical detector and cAMP by radioimmunoassay. The mean beta-adrenoceptor density (Bmax) of the control group was 60.1 +/- 9.5 fmol (n = 29) per 10(6) lymphocytes. In the study population, the density was decreased by 83% in LVP, 78% in LVV, 87% in MOL and 86% in RVP. Plasma norepinephrine was elevated by 89% in LVP and 60% in MOL, epinephrine by 43% in LVP, 50% in VOL, 115% in MOL and 20% in RVP, while dopamine was not significantly changed, and cAMP was slightly elevated in all four groups. Screening for activating mutational changes in the Gs alpha-protein gave negative results, possibly dissociating the elevation in plasma cAMP from stimulatory effects of such abnormalities in the Gs-protein signaling.(ABSTRACT TRUNCATED AT 250 WORDS)
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0767-3981
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
9
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
372-80
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:8566937-Adolescent,
pubmed-meshheading:8566937-Adult,
pubmed-meshheading:8566937-Aged,
pubmed-meshheading:8566937-Aortic Valve Stenosis,
pubmed-meshheading:8566937-Binding Sites,
pubmed-meshheading:8566937-Catecholamines,
pubmed-meshheading:8566937-Child,
pubmed-meshheading:8566937-Cyclic AMP,
pubmed-meshheading:8566937-Electrophoresis, Polyacrylamide Gel,
pubmed-meshheading:8566937-Female,
pubmed-meshheading:8566937-GTP-Binding Proteins,
pubmed-meshheading:8566937-Humans,
pubmed-meshheading:8566937-Lymphocytes,
pubmed-meshheading:8566937-Male,
pubmed-meshheading:8566937-Middle Aged,
pubmed-meshheading:8566937-Mitral Valve Stenosis,
pubmed-meshheading:8566937-Mutation,
pubmed-meshheading:8566937-Radioimmunoassay,
pubmed-meshheading:8566937-Receptors, Adrenergic, beta,
pubmed-meshheading:8566937-Rheumatic Heart Disease,
pubmed-meshheading:8566937-Ventricular Function, Left
|
| pubmed:year |
1995
|
| pubmed:articleTitle |
Characterization of lymphocyte beta-adrenoceptor activity and Gs-protein in patients with rheumatic heart valvular disease.
|
| pubmed:affiliation |
Department of Biological and Medical Research, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
|
| pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Controlled Clinical Trial
|